missing translation for 'onlineSavingsMsg'
Läs mer

TAK-220, MedChemExpress

Produktkod. 16473917
Encompass_Preferred
Change view
Klicka för att se tillgängliga alternativ
Kvantitet:
1 mg
5 mg
10 mg
50 mg
100 mg
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Produktkod. Kvantitet
16473917 50 mg
16440458 5 mg
16421909 1 mg
16417776 100 mg
16407998 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
Denna artikel kan inte returneras. Se returpolicy
Produktkod. 16473917 Leverantör Medchem Express Leverantörsnummer HY19974

Please to purchase this item. Need a web account? Register with us today!

Denna artikel kan inte returneras. Se returpolicy

MedChemExpress TAK-220 is a selective and orally bioavailable CCR5 antagonist, with IC50s of 3.5 nM and 1.4 nM for inhibition on the binding of RANTES and MIP-1α to CCR5, respectively, but shows no effect on the binding to CCR1, CCR2b, CCR3, CCR4, or CCR7

TAK-220 also selectively inhibits HIV-1, with EC50s of 1.2 nM (HIV-1 KK), 0.72 nM (HIV-1 CTV), 1.7 nM (HIV-1 HKW), 1.7 nM (HIV-1 HNK), 0.93 nM (HIV-1

Specifikationer

Kemiskt namn eller material TAK-220
CAS 333994-00-6
Färg Off-White
Anteckningar om renhetsgrad Research
Molekylformel C31H41ClN4O3
Kvantitet 50 mg
Löslighetsinformation DMSO : ≥ 50 mg/mL (90.39 mM)
LEDER O=C(C1CCN(C(C)=O)CC1)N(CCCN2CCC(CC3=CC=C(C(N)=O)C=C3)CC2)C4=CC=C(C)C(Cl)=C4
Molekylvikt (g/mol) 553.14
Formel vikt 553.14
Procent renhet 99.9%
Kvalitet Research
Fysisk form Solid
För användning med (applikation) COVID-19-anti-virus
Visa mer Visa mindre

Research purposes only

Produkttitel
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.